Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4

European Journal of Immunology

Volumn 28, Issue 10, 1998, Pages 3280-3290

  Galli, Grazia ^a   Annunziato, Francesco ^a   Mavilia, Carmelo ^a   Romagnani, Paola ^b   Cosmi, Lorenzo ^a   Manetti, Roberto ^a   Pupilli, Cinzia ^b   Maggi, Enrico ^a   Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Endocrinology Unit   (Italy)

Author keywords

CXCR4; HIV 1; IFN ; IL 4; T lymphocyte

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMORY CELL; MODEL; NORMAL HUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; VIRUS EXPRESSION;

CELLS, CULTURED; DOWN-REGULATION; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-4; RECEPTORS, CXCR4; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 0031654579     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199810)28:10<3280::AID-IMMU3280>3.0.CO;2-M     Document Type: Article

References (49)

1. Lane, H. C., Depper, J. M., Greene, W. C., Whazen, G., Waldmann, T. A. and Fauci, A. S., Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 1985. 313: 79-84.
2. Bowen, D. L., Lane, H. C. and Fauci, A. S., Immunopathogenesis of the acquired immunodeficiency syndrome. Ann. Intern. Med. 1985. 103: 704-709.
3. Fauci, A. S., Macher, A. M., Longo, D. L., Lane, H. C., Rook, A. H., Masur, H. and Gelmann, E. P., Acquired immunodeficiency syndrome: epidemiologic, clinic, immunologic, and therapeutic considerations. Ann. Intern. Med. 1984. 100: 92-106.
4. Cheng-Mayer, C., Seto, D., Tateno, M. and Levy, L. A., Biological features of HIV-1 that correlate with virulence in the host. Science 1988. 240: 80-82.
5. Tersmette, M., de Goede, R. E. Y., Al, B. J., Winkel, I. N., Gruters, R. A., Cuypers, H. T., Huisman, H. G. and Miedema, F., Differential sycncitium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncitium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 1988. 62: 2026-2032.
6. Asjo, B., Morfeldt-Manson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K. and Fenyo, E. M., Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986. 2: 660-662.
7. Schuitemaker, H., Kootstra, N. A., de Goede, R. E., de Wolf, F., Miedema, F. and Tersmette, M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncitium-inducing ability in primary T cell culture. J. Virol. 1991. 65: 356-363.
8. Connor, R. I., Mohri, H., Cao, Y. and Ho, D. D., Increased viral burden and cytopathicity correlate temporally with CD4+ T lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 1993. 67: 1772-1778.
9. Choe, H., Farazan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J., The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996. 85: 1135-1148.
10. Berson, J. F., Long, D., Doranz, B. J., Rucker, J., Jirik, F. R. and Doms, R. W., A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J. Virol. 1996. 70: 6288-6295.
11. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996. 272: 872-877.
12. Mosmann, T. R. and Coffman, R. L., Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
13. Romagnani, S., Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 1994. 12: 227-257.
14. Abbas, A. K., Murphy, K. M. and Sher, A., Functional diversity of T lymphocytes. Nature 1996. 383: 787-793.
15. Clerici, M. and Shearer, G. M., A Th1 to Th2 switch is a critical step in the etiology of HIV infection, Immunol. Today 1993. 14: 107-111.
16. Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C. W., Wynn, T. A. and Shearer, G., Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 1993. 91: 759-765.
17. Graziosi, C., Pantaleo, G., Gant, K. R., Fortin, J.-P., Demarest, J. F., Cohen, O. J., Sekaly, R. P. and Fauci, A. S., Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994. 265: 248-252.
18. Miedema, F., Meyaard, C., Koot, M., Klein, M. R., Roos, M. T., Groenink, M., Fouchier, R. A. and Van't Wout, A. B., Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 1994. 140: 35-72.
19. Maggi, E., Mazzetti, M., Ravina, A., Annunziato, F., De Carli, M., Piccinni, M. P., Manetti, R., Carbonari, M., Pesce, A. M., Del Prete, G. F. and Romagnani, S., Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994. 265: 244-248.
20. Vyarnakam, A., Matear, P. M., Martin, S. J. and Wagstaff, M., Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells. Immunology 1995. 86: 85-90.
21. Tanaka, Y., Koyanagi, Y., Tanaka, R., Kumazawa, Y., Nishimura, T. and Yamamoto, N., Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1. J. Virol. 1997. 71: 465-470.
22. Meyaard, L., Otto, S. A., Hooibrink, B. and Miedema, F., Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. J. Clin. Invest. 1994. 94: 1947-1952.
23. Swain, S. L., Weinberg, A. D., English, M. and Huston, G., IL-4 directs the development of Th2-like helper effectors. J. Immunol. 1990. 145: 3796-3806.
24. Seder, R. A. and Paul, W. E., Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994. 12: 635-674.
25. Hsieh, C.-S., Macantonia, S. E., Tripp, S. F., Wolf, S. F., O'Garra, A. and Murphy, K. M., Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993. 260: 547-549.
26. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M.-P., Maggi, E., Trinchieri, G. and Romagnani, S., Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 1993. 177: 1199-1204.
27. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A. and Mackay, C. R., The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 1997. 94: 1925-1930.
28. Annunziato, F., Manetti, R., Cosmi, L., Galli, G., Heusser, C. H., Romagnani, S. and Maggi, E., Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur. J. Immunol. 1997. 27: 2239-2244.
29. Annunziato, F., Manetti, R., Tomasévic, L., Giudizi, M.-G., Biagiotti, R., Giannò, V., Germano, P., Mavilia, C., Maggi, E. and Romagnani, S., Expression and release of LAG-3-associated protein by human CD4+ T cells are associated with IFN-γ. FASEB J. 1996. 10: 767-776.
30. Jourdan, P., Abbal, C., Nora, N., Hori, T., Huchiyama, T., Vendrell, J.-P., Bousquet, J., Taylor, N., Pène, J. and Yssel, H., IL-4 induces functional cell surface expression of CXCR4 on human T cells. J. Immunol. 1998. 160: 4153-4157.
31. Connor, R. I. and Ho, D. D., Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 1994. 68: 4400-4408.
32. Roos, M. T. L., Lange, J. M. A., de Goede, R. E. Y., Coutinho, R. A., Schellekens, P. T. A., Miedema, F. and Tersmette, M., Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 1992. 165: 427-432.
33. Tersmette, M., Gruters, R. A., de Wolf, F., de Goede, R. E., Lange, J. M., Schellekens, P. T., Goudsmit, J., Huisman, H. G. and Miedema, F., Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency virus syndrome: studies on sequential isolates. J. Virol. 1989. 63: 2118-2125.
34. Tersmette, M., Lange, J. M. A., de Goede, R. E. Y., de Wolf, F., Eeftink-Schattenkerk, J. K. M., Schellenkens, P. T. A., Coutinho, R. A., Huisman, J. G., Goudsmit, J. and Miedema, F., Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989. I: 983-985.
35. Connor, R. I., Sheridan, K. E., Ceradini, E., Choe, S. and Landau, N. R., Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 1997. 185: 621-628.
36. Chehimi, J., Starr, S. E., Frank, I., D'Andrea, A., Ma, X., McGregor, R. R., Seumelier, J. and Trinchieri, G., Impaired interleukin-12 production in HIV-infected patients. J. Exp. Med. 1994. 179: 1361-1366.
37. Nakamura, T., Lee, R. K., Nam, S. Y., Al-Ramadi, B. K., Koni, P. A., Bottomly, K., Podack, E. R. and Flavell, R. A., Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J. Immunol. 1997. 158: 2090-2098.
38. Smith, C. A., Gruss, H. J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G. and Jenkins, N. A., CD30 antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993. 73: 1349-1360.
39. Biswas, P., Smith, C. A., Goletti, O., Hardy, E. C., Jackson, R. W. and Fauci, A. S., Crosslinking of CD30 induces HIV expression in chronically infected T cells. Immunity 1995. 2: 587-596.
40. Maggi, E., Annunziato, F., Manetti, R., Biagiotti, R., Giudizi, M. G., Ravina, A., Almerigogna, F., Boiani, N., Alderson, M. and Romagnani, S., Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Immunity 1995. 3: 251-255.
41. McDonald, P. P., Cassatella, M. A., Bald, A., Maggi, E., Romagnani, S., Gruss, H. J. and Pizzolo, G., CD30 ligation induces nuclear factor-kB activation in human T cell lines. Eur. J. Immunol. 1995. 25: 2870-2876.
42. Tsitsikow, E. N., Wright, D. A. and Geha, R. S., CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Proc. Natl. Acad. Sci. USA 1997. 94: 1390-1395.
43. Isreal-Biet, D., Labrousse, F., Tourani, J. M., Sors, H., Andrieu, J. M. and Even, P., Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J. Allergy Clin. Immunol. 1994. 89: 68-75.
44. Romagnani, S., Role for Th1/Th2 cytokine in HIV infection. Immunol. Rev. 1994. 140: 73-92.
45. Pizzolo, G., Vinante, F., Morosato, L., Nadali, G., Chilosi, M., Ghandini, G., Sinicco, A., Raiteri, R., Semenzato, G., Stein, H. and Perona, G., High serum levels of soluble form of CD30 molecule in the early phase of HIV-1 infection is an independent predictor of progression to AIDS. AIDS 1994. 8: 741-745.
46. Bentwich, Z., Kalinkovich, A. and Weisman, Z., Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 1995. 16: 187-191.
47. Kup, R. A. and Ho, D. D., Quantitative culture assay or HIV-1 in peripheral blood. Aldovini, A. and Walker, B. D. (Eds.) Techniques in HIV Research. Stockton, New York 1994, pp 107-112.
48. Ou, C.-Y., Kwok, S., Mitchell, S. W., Mack, D. H., Sninsky, J. J., Krebs, J. W., Fedrino, P., Warfield, D. and Schochetman, G., DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988. 239: 295-297.
49. Schmidt, B. L., A rapid chemiluminescence detection method for PCR-amplified HIV-1 DNA. J. Virol. Methods. 1991. 32: 233-244.